NLRP1 Antikörper (AA 1-146) (HRP)

Produktnummer ABIN7160820

Produktdetails anti-NLRP1 Antikörper (HRP)

Target: NLRP1 (NLR Family, Pyrin Domain Containing 1 (NLRP1))

Bindungsspezifität: AA 1-146

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser NLRP1 Antikörper ist konjugiert mit HRP

Applikation: ELISA

Kreuzreaktivität: Human

Aufreinigung: >95%, Protein G purified

Immunogen: Recombinant Human NACHT, LRR and PYD domains-containing protein 1 protein (1-146AA)

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Details zu NLRP1

Target: NLRP1 (NLR Family, Pyrin Domain Containing 1 (NLRP1))

Andere Bezeichnung: NLRP1 (NLRP1 Produkte)

Synonyme: CARD7 antikoerper, CIDED antikoerper, CLR17.1 antikoerper, DEFCAP antikoerper, DEFCAP-L/S antikoerper, NAC antikoerper, NALP1 antikoerper, PP1044 antikoerper, SLEV1 antikoerper, VAMAS1 antikoerper, NLR family pyrin domain containing 1 antikoerper, NLRP1 antikoerper, Nlrp1 antikoerper

Hintergrund:

Background: As the sensor component of the NLRP1 inflammasome, plays a crucial role in innate immunity and inflammation. In response to pathogens and other damage-associated signals, initiates the formation of the inflammasome polymeric complex, made of NLRP1, CASP1, and possibly PYCARD. Recruitement of proCASP1 to the inflammasome promotes its activation and CASP1-catalyzed IL1B and IL18 maturation and secretion in the extracellular milieu. Activation of NLRP1 inflammasome is also required for HMGB1 secretion. The active cytokines and HMGB1 stimulate inflammatory responses. Inflammasomes can also induce pyroptosis, an inflammatory form of programmed cell death (PubMed:22665479, PubMed:17418785). May be activated by muramyl dipeptide (MDP), a fragment of bacterial peptidoglycan, in a NOD2-dependent manner (PubMed:18511561). Contrary to its mouse ortholog, not activated by Bacillus anthracis lethal toxin (PubMed:19651869). It is unclear whether isoform 2 is involved in inflammasome formation. It is not cleaved within the FIIND domain, does not assemble into specks, nor promote IL1B release (PubMed:22665479). However, in an vitro cell-free system, it has been shown to be activated by MDP (PubMed:17349957). Binds ATP (PubMed:11113115, PubMed:15212762).

Aliases: CARD 7 antibody, CARD7 antibody, Caspase recruitment domain protein 7 antibody, Caspase recruitment domain-containing protein 7 antibody, CLR17.1 antibody, Death effector filament forming Ced 4 like apoptosis protein antibody, Death effector filament-forming ced-4-like apoptosis protein antibody, DEFCAP antibody, DEFCAP L/S antibody, DKFZp586O1822 antibody, KIAA0926 antibody, LRR and PYD domains-containing protein 1 antibody, NAC alpha/beta/gamma/delta antibody, NAC antibody, NACHT antibody, NACHT leucine rich repeat and PYD containing 1 antibody, NACHT leucine rich repeat and PYD pyrin domain containing 1 antibody, NACHT leucine rich repeat and pyrin domain containing 1 antibody, NACHT LRR and PYD containing protein 1 antibody, NALP 1 antibody, NALP1 antibody, NALP1_HUMAN antibody, NLR family pyrin domain containing 1 antibody, NLRP 1 antibody, NLRP1 antibody, NLRP1 protein antibody, Nucleotide binding domain and caspase recruitment domain antibody, Nucleotide binding oligomerization domain leucine rich repeat and pyrin domain containing 1 antibody, Nucleotide-binding domain and caspase recruitment domain antibody, PP 1044 antibody, PP1044 antibody

UniProt: Q9C000

Pathways: Positive Regulation of Endopeptidase Activity, Inflammasome